Metabolic Modeling Predicts Unique Drug Targets in Lyme Disease Pathogen B. burgdorferi – TUSM’s Peter Gwynne, PhD
Lyme disease expert Peter Gwynne, PhD, presented on “Metabolic Modeling Predicts Unique Drug Targets in the Lyme Disease Pathogen Borrelia burgdorferi” for the Levy CIMAR's February 2023 Science Seminar. Dr. Gwynne is interested in Borrelia burgdorferi, which causes Lyme disease,
Role of Bacteriophages in the Evolution of Pathogenic Vibrios and Lessons for Phage Therapy
Adv Exp Med Bio.; February 16, 2023
Low frequency of allergy referral for penicillin allergy evaluation in an urban Boston primary care setting
J. Allergy Clin. Immunol. Glob.; February 6, 2023
